|
(2,5-二羧基苯基)硼酸(含不同量的酸酐)
|
B302461-5g
|
≥98% |
1351221-58-3 |
5g
|
¥ 2151.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
聚季铵盐-28
|
B302382-5L
|
20 wt. % in H2O |
131954-48-8 |
5L
|
¥ 2157.9
|
现货 |
|
0 |
阿拉丁 |
|
聚季铵盐-28
|
B302382-1L
|
20 wt. % in H2O |
131954-48-8 |
1L
|
¥ 506.9
|
现货 |
|
0 |
阿拉丁 |
|
4-溴-5-硝基苯-12-二胺
|
B302227-250mg
|
≥95% |
113269-07-1 |
250mg
|
¥ 596.9
|
现货 |
|
0 |
阿拉丁 |
|
4-溴-5-硝基苯-12-二胺
|
B302227-1g
|
≥95% |
113269-07-1 |
1g
|
¥ 2087.9
|
现货 |
|
0 |
阿拉丁 |
|
(+)-生物素酰胺基己酸肼
|
B293846-250mg
|
≥93% |
109276-34-8 |
250mg
|
¥ 1334.9
|
现货 |
|
0 |
阿拉丁 |
|
二[2-(4,6-二氟苯基)-4-(2,4,6-三甲基苯基)吡啶-C2,N]吡啶甲酰合铱(III)
|
B293078-25mg
|
≥98% |
1435909-76-4 |
25mg
|
¥ 823.9
|
现货 |
|
0 |
阿拉丁 |
|
二[2-(4,6-二氟苯基)-4-(2,4,6-三甲基苯基)吡啶-C2,N]吡啶甲酰合铱(III)
|
B293078-100mg
|
≥98% |
1435909-76-4 |
100mg
|
¥ 2059.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
5-溴-2,2'-联吡啶
|
B290599-5g
|
≥98% |
15862-19-8 |
5g
|
¥ 869.9
|
现货 |
|
0 |
阿拉丁 |
|
5-溴-2,2'-联吡啶
|
B290599-25g
|
≥98% |
15862-19-8 |
25g
|
¥ 3749.9
|
现货 |
|
0 |
阿拉丁 |
|
5-溴-2,2'-联吡啶
|
B290599-250mg
|
≥98% |
15862-19-8 |
250mg
|
¥ 52.9
|
现货 |
|
0 |
阿拉丁 |
|
5-溴-2,2'-联吡啶
|
B290599-10g
|
≥98% |
15862-19-8 |
10g
|
¥ 1599.9
|
现货 |
|
0 |
阿拉丁 |
|
B2,促进亨廷顿氏病和帕金森氏病的包涵体形成
|
B288906-250mg
|
≥98%(HPLC) |
115687-05-3 |
250mg
|
¥ 2107.9
|
现货 |
|
0 |
阿拉丁 |
|
B2,促进亨廷顿氏病和帕金森氏病的包涵体形成
|
B288906-100mg
|
≥98%(HPLC) |
115687-05-3 |
100mg
|
¥ 1227.9
|
现货 |
|
0 |
阿拉丁 |
|
BPTES,变构谷氨酰胺酶(GLS1)抑制剂
|
B288896-250mg
|
≥95%(HPLC) |
314045-39-1 |
250mg
|
¥ 2180.9
|
现货 |
|
0 |
阿拉丁 |
|
BPTES,变构谷氨酰胺酶(GLS1)抑制剂
|
B288896-1g
|
≥95%(HPLC) |
314045-39-1 |
1g
|
¥ 5297.9
|
现货 |
|
0 |
阿拉丁 |
|
BPTES,变构谷氨酰胺酶(GLS1)抑制剂
|
B288896-100mg
|
≥95%(HPLC) |
314045-39-1 |
100mg
|
¥ 1254.9
|
现货 |
|
0 |
阿拉丁 |
|
BRD 6989,CDK8抑制剂
|
B288741-5mg
|
≥98%(HPLC) |
642008-81-9 |
5mg
|
¥ 232.9
|
现货 |
|
0 |
阿拉丁 |
|
BRD 6989,CDK8抑制剂
|
B288741-25mg
|
≥98%(HPLC) |
642008-81-9 |
25mg
|
¥ 462.9
|
现货 |
|
0 |
阿拉丁 |
|
BRD 6989,CDK8抑制剂
|
B288741-100mg
|
≥98%(HPLC) |
642008-81-9 |
100mg
|
¥ 740.9
|
现货 |
|
0 |
阿拉丁 |
|
BRD 4354,HDAC5和HDAC9抑制剂
|
B288731-5mg
|
≥98%(HPLC) |
315698-07-8 |
5mg
|
¥ 586.9
|
现货 |
|
0 |
阿拉丁 |
|
BRD 4354,HDAC5和HDAC9抑制剂
|
B288731-25mg
|
≥98%(HPLC) |
315698-07-8 |
25mg
|
¥ 2223.9
|
现货 |
|
0 |
阿拉丁 |
|
BRD 4354,HDAC5和HDAC9抑制剂
|
B288731-100mg
|
≥98%(HPLC) |
315698-07-8 |
100mg
|
¥ 5560.9
|
现货 |
|
0 |
阿拉丁 |
|
5-BDBD,P2X4拮抗剂
|
B288553-5mg
|
Moligand™, ≥99%(HPLC) |
768404-03-1 |
5mg
|
¥ 759.9
|
现货 |
|
0 |
阿拉丁 |